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A bstract
Background: Treatment of headache disorders is not always optimal. Patients are treated in multiple 
ways, and the lack of scientific arguments for referral and the insufficient implementation of guidelines 
result in unclear treatment strategies.
The coexistence of headache and neck pain can lead to the referral to a musculoskeletal physiotherapist. 
This treatment can only be successful if an underlying cervical segmental dysfunction is present. In such 
cases a physical treatment can be a valuable option that should be considered.
The aim of this study is to identify prognostic therapeutic patient characteristics and to increase the 
number of correct physiotherapy referrals.
Methods/design: This trial is designed to identify patient characteristics which can influence the 
prognosis of the patient. Patients with recurrent headache and co-existent neck pain are recruited via a 
multicenter setup. After screening for eligibility, subjects are tested at baseline and randomly allocated to 
one of two treatment groups. Testing includes the administering of questionnaires (a Headache Diagnosis 
Questionnaire, Headache Inventory List and the Headache Impact Test (HIT-6)) and physical tests 
(Thermal Stimuli, Manual Cervical Spine Examination and Pressure Algometry). Treatment groups are a 
usual care group (UC) administered by the General Practitioner (GP) and a usual care plus musculoskeletal 
physiotherapy treatment group (UCMT). UC is based on the Dutch GP Guideline for Headache. UCMT 
consists of the UC plus a combination of exercises and spinal cervical mobilisations. Follow-up 
measurements consist of the completion of the Headache Inventory List, the HIT-6 and scoring of the 
global perceived effect (GPE). The latter allowing the distinction between responders (positive effect) and 
non-responders (no effect or worse). Logistic regression analysis will be used to identify the specific 
patient characteristics of the responders and the non-responders. The additional value of the 
musculoskeletal physiotherapy will be examined. Follow-up measurements up to 52 weeks are scheduled.
Discussion: This trial aims to identify prognostic patient characteristics, in order to supply a useful 
diagnostic tool for all health care workers, dealing with headache sufferers.
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Background
Headache is a common disorder with a high impact, both 
on the socio-economic level and on the level of the indi­
vidual sufferer [1-3]. Not all headache patients seek head­
ache treatment, although severe pain and disability have 
been reported even in large proportions of non-care seek­
ers [4]. Patients do not look for treatment partially out of 
ignorance of effective treatments or because of previous 
negative experiences [2,5].
Guidelines for headache management in primary care are 
available [6,7]. These guidelines provide diagnostic and 
therapeutic algorithms and stepped treatment plans for 
the most common headache types. Apparently they are 
insufficiently applied in daily practice as patients are fre­
quently referred to neurology clinics after no more than 
one visit to the general practitioners (GP) office [8].
Physical treatments of the cervical spine, provided by 
musculoskeletal physiotherapists can be considered as a 
treatment option in headache sufferers. The effects of 
musculoskeletal physiotherapy for various headache 
types are reported both in RCT's and systematic reviews 
[9-16]. The combination of mobilisations and low-load 
exercises focussing on the cranio-cervical flexion is of par­
ticular interest nowadays [9,13]. The conclusions of sys­
tematic reviews are not firm due to methodological 
limitations of the selected studies, but there are indica­
tions that musculoskeletal physiotherapy directed to the 
cervical spine can be beneficial for some headache 
patients [11,15]. Reductions in headache frequency, 
intensity and duration of headache attacks have been 
reported [9,13]. Dowson et al. recommend physical ther­
apy (muscle relaxing and mobilising exercises) for those 
patients who report neck stiffness [17,18]. The neck-head- 
ache relationship is however not always causal: neck pain 
experienced by migraine patients for example can be a 
result of sensitization [19]. The co-existence of headache 
and neck pain and/or the presence of neck stiffness might 
therefore not be a sufficient indication to prescribe physi­
cal treatment of the cervical spine.
These therapeutic uncertainties contribute to patients' 
treatment dissatisfaction. Relatively high percentages of 
headache sufferers are not satisfied with the headache care 
they receive. Harpole and co-workers investigated the 
headache burden and patient satisfaction with existing 
management in  primary care, using patient-administered 
surveys. Of the 385 responders, who all contacted a GP 
because of their headache, 48 % reported problems with 
headache management and 17 % were dissatisfied with 
the headache care. Patients with a high headache-related 
impairment reported more problems with their headache 
management [20]. Walling et al. found that 26 % were 
dissatisfied in their sample of 447 migraine patients [21].
The prevalence and burden of headache, the dissatisfac­
tion percentages and the diversity in headache treatments, 
call for a refinement of headache management.
The identification prior to the start of a treatment, of 
patients whom might react properly to the treatment, is 
necessary to reduce the risk of a negative outcome. For this 
purpose, patient characteristics which predict the treat­
ment outcome (prognostic characteristics) need to be 
determined.
Prognostic factors are multifactorial. Jull and Stanton ana­
lysed the results of 152 CErvicogenic Headache (CEH) 
patients who participated in one of the three active treat­
m ent groups in a headache trial [9]. The prognostic value 
of socio-demographic factors, headache features, physical 
impairments of the cervical spine, neck pain and disability 
and patients' perceptions of influences on their headaches 
(locus of control) was investigated. They were unable to 
identify a systematic pattern of prognostic factors. Only 
the presence of light-headedness appeared to be a clini­
cally relevant predictor of a bad outcome. Of the physical 
tests only joint pain on palpation had a prognostic value 
[22]. Of their tests only this palpation could be used for 
prognostic uses.
Our study has a double aim. Our primary aim is to analyse 
the prognostic value of a series of physical tests. Our sec­
ondary aim is to compare two currently applied treatment 
strategies, being the usual care (UC) administered by a 
medical doctor following a stepped guideline [7], and the 
UC plus a musculoskeletal physiotherapy treatment pro­
tocol (UCMT), described by Jull et al [9].
Our research questions are: first, can we identify prognos­
tic patient characteristics, and second, what is the addi­
tional value of a musculoskeletal physiotherapy approach 
in the treatment of headache disorders?
Methods/design 
Study design
A randomised clinical trial with blinded assessment and 
unblinded treatment and with a follow-up period of 12 
months was developed. The research protocol was 
approved by the Medical Ethics Committees of the Uni­
versity Hospital of the Vrije Universiteit Brussel (UZ Brus­
sel) and of the University Hospital of Antwerp (UZA).
Patients selection
Using a multicenter setup, patients will be recruited at GPs 
offices, from outpatient clinics of the neurology depart­
m ent of the academic hospitals UZ Brussel and UZA and 
via advertisements.
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All participating medical doctors (GP's and neurologists) 
were contacted and personally informed about the study 
protocol. Additional information is provided on an 
informative website [23].
The advertisements contain a weblink to an informative 
recruitment website [24]. On this site detailed informa­
tion is provided, followed by an online eligibility screen­
ings procedure.
Different recruitment strategies can result in a heteroge­
nous study population. This will not necessarily affect 
treatment outcome [25]. Subgroups will be compared at 
baseline. In case differences are found these will be taken 
into account in the statistical analysis (see section 'Analy­
ses').
In- and exclusion criteria
Dutch speaking patients with a combination of recurrent 
headache and neck pain since m inimum two m onths and 
at least twice a m onth with an active help-request (who 
consider to undergo treatment) are recruited. They have to 
be at least 18 years old and be willing to participate. Sub­
jects are excluded in case of cluster headache or trigeminal 
neuralgia. To avoid false positive tests with the quantita­
tive sensory tests (see description of measurements), 
patients with peripheral neuropathies and co-morbidity 
of chronic musculoskeletal pain will be excluded. Because 
of the neck mobility tests, people with rheumatoid arthri­
tis, Down syndrome and/or a history of neck surgery will 
be excluded. The presence of red flags for headache (warn­
ing signs for serious causes of the headache) is an extra 
exclusion criterion. Pregnant women are also excluded, as 
pregnancy influences the frequency and intensity of head­
aches with migraine properties.
To avoid biased patients (with treatment preferences), we 
excluded patients who received physiotherapy treatment 
for their headaches during the last 12 months or patients 
whose prescribed medication was changed during the last 
two months.
The included headache types are migraine, tension-type 
headache and CEH. For migraine and tension-type head­
ache the IHS criteria are used [26], for CEH the criteria of 
the Cervicogenic Headache International Study Group 
(CHISG) [27].
For the patients recruited via internet sites and advertise­
ments, an additional exclusion criteria is set: a HIT-6 score 
of at least 56 points. From this level, the HIT-6 scoring 
advises the patient to contact his/her GP in order to start 
a treatment [28].
All subjects sign a written informed consent.
Baseline measurements
Baseline measurements consist of two parts: the comple­
tion of questionnaires and physical tests. All baseline 
measurements are performed by a blinded examiner/ 
rater, as subjects are allocated at random after the baseline 
measurements (see below: Randomization).
A. Questionnaires
All questionnaires can be completed online using PHP- 
surveyor [29]. In case a participant does no t have the 
opportunity to fill in the questionnaires online, a paper 
version including an addressed and stamped envelope is 
provided. The rater is blinded: the online version is com­
pleted by the participants themselves, the paper versions 
are inserted in the computer software by an independent, 
blinded rater.
■  Headache Diagnosis Questionnaire
This questionnaire was developed to screen for CEH [30]. 
It consists of 56 questions in total: 34 concerning head­
ache, 15 concerning neck pain and 7 concerning shoulder 
pain. It registers headache-associated features in a system­
atic way. Additionally it creates an inventory of pain 
intensity (Visual Analogue Scale, VAS) of headache, neck 
pain and shoulder pain (average pain intensity over the 
last three months and at the m om ent of fulfilment of the 
questionnaire), frequency and duration of the headache 
history. It was developed as a CEH questionnaire and 
additional questions screening for migraine and tension­
type headache characteristics were added. The question­
naire will be validated throughout the trial [30,31].
■  The Headache Impact Test (HIT-6) [3 2 ]
The HIT-6 is a short questionnaire, consisting of 6 items: 
pain intensity, social functioning, role functioning, vital­
ity, cognitive functioning and psychological distress. It 
has a recall period of four weeks. Scores vary between 36 
and 78. Higher scores correspond with a higher headache 
burden.
The six items are derived from a total pool of 89 items, 54 
items from the computer based HIT pool and 35 items 
that were proposed by headache experts [32]. Its psycho­
metric properties have been investigated extensively 
[32,33]. Reliability analyses (internal consistency, alter­
nate forms, test-retest) are good to excellent (scores rang­
ing from 0.78 to 0.90). Construct validity has been 
investigated using the SF-8 as criterion, and negative cor­
relations were found. The HIT-6 is able to differentiate 
between mild, moderate and severe headache forms. Pain, 
role functioning and psychological distress are the most 
differentiating items. A difference of three points is 
believed to be clinically im portant (responsiveness). 
These results were generated in a general population [32],
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and were recently confirmed in a population of recent 
headache sufferers recruited in a headache centre [33].
■ H e ad a ch e  Inventory List
This questionnaire is used to register the frequency and 
intensity of the headache, medication use (both over-the- 
counter and prescription), headache-related professional 
care and absenteeism. A similar patient administered 
questionnaire has been used by Peters et al. [34].
Pain intensity is registered on a VAS for pain at the 
m om ent of completion of the questionnaire and for the 
average pain of the last 4 weeks. Medication intake is 
monitored, precautionary and treatment medication, 
both on prescription or over-the-counter.
Headache-related professional care is monitored provid­
ing a list of health-care workers who might be contacted 
by a headache patient (e.g. pharmacist, nurse, and psy­
chologist). Patients have to mark those health-care work­
ers they contacted as well as the frequency of the visits. 
This registration will allow the analysis of additional ther­
apies that might interfere with the treatment protocol of 
the study.
Sick leave is scored by the number of absence days.
For all questionnaires a recall period of four weeks is cho­
sen, in correspondence with the recall period of the HIT-
6. At baseline and at the last administration of the ques­
tionnaires (follow-up at 52 weeks) the absenteeism of the 
past 12 months is monitored.
B. Physical tests
Physical examination of the cervical spine
The cervical spine is examined using a manual rotation
test and a pain provocation test.
The rotation test is performed for both rotations (left and 
right) at the C0-2 and C2-7 regions. It is scored for mobil­
ity (hyper/hypo or normal), endfeel (too hard, normal, 
too soft or empty) and for the onset of pain (yes/no). The 
test is considered positive if two out of three criteria were 
positive, i.e. hyper- or hypo-mobility, too hard or soft or 
empty endfeel, and the provocation of pain.
The pain provocation test is the adapted Spurling test 
(passive lateral flexion, homolateral rotation, extension 
and axial compression at the end). It is performed on all 
segments starting at C0-1 and descending till C6-7. It is 
scored for pain provocation and endfeel. When pain is 
provoked during this test, a VAS (0 mm -  100 mm) is 
recorded. If subjects rate their pain > 20 mm on a VAS, this 
test is considered positive.
These tests can discriminate between asymptomatic con­
trols and patients with neck pain [35]. In this study we 
apply them to identify an underlying painful segmental 
dysfunction.
Thermal and pressure stimuli
Thermal and pressure stimuli are used to detect sensitisa­
tion. Stimuli are applied in cranial and extra-cranial 
regions. To screen for central sensitization, measurements 
were also taken on the dorsal side of the index, on the tibi­
alis anterior (pressure) and on the thenar (temperature).
Thermal stimuli will be investigated using the TSA II Ther­
motest (Medoc Advanced Medical Systems Ltd. 1 
Ha'Dekel Street P.O. Box 423, Ramat Yishai 30095 Israel). 
A thermode of 30 x 30 mm is attached first to the skin of 
the hand (palmar thenar, C6), next to the mastoid process 
(C2) and finally to the temple (trigeminal nerve). Starting 
from a baseline temperature of 32°C, the intensity of the 
stimulus will vary following the m ethod of limits protocol 
(+/- 1°C/s). Four modalities are tested: cold and warm 
sensation (CS and WS) and cold and heat pain detection 
thresholds (CP and HP). First subjects are asked to press a 
button as soon a change in temperature is perceived (CS 
and WS, 4 stimuli). Second they have to push the button 
when the temperature stimulus is perceived as unpleas­
ant/painful (CP and HP, 3 stimuli). All measurements are 
performed bilaterally. The average of the repetitions is 
used for further calculations.
The sequence of the thermal stimuli is chosen to familiar­
ise the subjects with the test: it is reassuring to have the 
first set of stimuli on the hand and not on the head, which 
is the site of the complaints. This method has been shown 
to be reliable [36].
Pressure stimuli are measured using a hand held algom- 
eter (Somedic AB, Farsta, Sweden). Pain detection thresh­
olds will be measured on the temple, the mastoid process, 
the dorsal side of the index and on the tibialis anterior 
muscle. The average of three measurements will be used 
for further calculations. Subjects have to report when the 
feeling of pressure alone changes into a feeling of pressure 
and pain.
Quantitative Sensory Tests are psychophysical tests. To 
increase the reliability and ecological validity of the tests, 
all measurements will be performed at the participants' 
home.
Follow-up measurements
After approximately 7, 12, 26 and 52 weeks, participants 
will be asked to complete the Headache Inventory List and 
HIT-6 again. For all questionnaires a recall period of four
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weeks is chosen, in correspondence with the recall period 
of the HIT-6.
The global perceived effect (GPE) is measured using a 7 
point scale, ranging from 'completely recovered' to 'worse 
than ever'. This way of measuring GPE has been used in 
similar studies in which the effect of commonly applied 
therapeutic approaches have been compared [37,38]. 
Responders (positive effect) and non-responders (no 
effect or worse) can be identified.
The follow-up measurements are also available online 
ensuring a blinded rater assessment. The questionnaires 
which are returned in paper version (from participants 
without internet connection) will be inserted in the soft­
ware by an independent blinded rater.
Primary and secondary outcome measures
Two primary outcome measures will be used in this study:
GPE and the HIT-6 score.
Reduction in headache frequency, headache pain inten­
sity, medication intake, absenteeism and looking for pro­
fessional help will be used as secondary outcome 
measures.
Interventions
The UCMT group will receive a musculoskeletal physio­
therapy treatment during 6 weeks following the protocol 
described by Jull et al. [10,11]. It consists of a combina­
tion of spinal mobilisations and exercise therapy. Spinal 
mobilisations consist of low and/or high-velocity cervical 
joint mobilization techniques. Each therapist can decide 
the technique of choice based on his own clinical skills 
and the patient's situation. Therapeutic exercises consist 
of low-load endurance exercises, more precisely cranio 
cervical flexion exercises. A maximum of 12 sessions 
(twice a week over a period of 6 weeks) is provided. Each 
session lasts approximately 30 minutes.
All participants receive a letter containing recommenda­
tions for treatment, based on the available evidence. This 
letter is to be handed over to the therapist. After the six 
weeks treatment period, the therapists will be contacted 
by phone to check for treatment integrity.
As a guideline for the UC treatment, the protocol from the 
Dutch College of GPs is used. It consists of a stepped 
approach to diagnose and treat primary headache disor­
ders. In the Flemish part of Belgium this is the guideline 
with the lowest access threshold. The GP receives an email 
containing a weblink to the Dutch College of GPs guide­
line [7]. In this treatment group treatment integrity will be 
analysed via the Headache Inventory List, which is to be 
completed in the follow-up measurements.
Randomisation
After baseline measurements patients are randomised. 
Subjects are randomised using blinded envelopes, using a 
pre-stratification for the headache diagnosis. So, an enve­
lope for migraine, tension-type headache and CEH is pro­
vided. Each envelope contains 10 notes, five mentioning 
usual care and five mentioning usual care plus manual 
therapy. This to ensure that for each 10 patients with the 
same diagnosis, the same number of patients is ran­
domised in one of the two treatment groups. Due to the 
randomisation after testing all tests are performed by a 
blinded rater.
Statistical analyses, power and sample size calculation
The prognostic capacity of the initial series of tests (phys­
ical examination of the cervical spine and QST) will be 
calculated by means of a logistic regression analysis, com­
paring the results of the responders with those of the non­
responders. Instead of starting with a full regression 
model, two known prognostic factors, derived from the 
study from Jull and Stanton [8] will be included in the 
analysis a priori. Those two factors are 'light-headedness' 
and 'joint pain on palpation'. Consequently a backwards 
stepwise selection will be used, including the two known 
factors in the smaller models. Differences at baseline 
between the two treatment groups will be included in the 
regression models as potential prognostic factors. The 
plausibility of the signs will be considered to check the 
logical contribution of each factor in the model. The 
power of the obtained models will be analysed via the 
area under the ROC-curve.
Group differences and effect sizes can be calculated for 
headache intensity and frequency, medication intake, 
HIT-6 scores and absenteeism. The number of responders 
and non-responders in both groups will be compared. 
GPE is a dichotomous variable. Sample size calculations 
with a significance level of p < 0.05, an event rate of 0.50 
in the usual care group and of 0.70 in the usual care plus 
musculoskeletal physiotherapy group a power of 80% and 
an equal amount of subjects in both treatment groups 
result in a sample size of 93 subjects in each treatment 
group. This results in a total of 186 subjects.
The results of all subjects will be analysed, regardless of 
their treatment adherence (intention-to-treat analysis).
Discussion
This study aims to improve the care for headache patients. 
Therefore we compare two commonly applied therapeutic 
strategies: the usual care, administered by the GP, and 
usual care plus musculoskeletal physiotherapy treatment. 
We primarily want to screen for prognostic patient charac­
teristics.
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For the selection of patients we start from the clinical pres­
entation of symptoms: we look for patients with a combi­
nation of headache and neck pain. We not only focus on 
CEH, but allow migraine and tension-type headache 
patients to be included as well. We believe this is justified 
because of the common combination of symptoms.
Is it ethical to provide musculoskeletal physiotherapy 
treatment to patients with migraine symptoms? Several 
systematic reviews have been performed concerning the 
value of physical treatments directed to the cervical spine 
in headache disorders such as migraine [10,11,39]. These 
reviews were unable to draw firm conclusions due to the 
methodological quality of the included RCTs. However, 
there are indications that physical treatments can be ben­
eficial. There is no group that receives only musculoskele­
tal physiotherapy treatment. The combination with the 
GP care is allowed at all times. Prohibiting the use of med­
ication, certainly during a headache attack, would be 
unethical.
We use a diagnostic headache questionnaire. The value of 
diagnostic questionnaires in comparison with a clinical 
interview has been studied [40]. Questionnaires have 
their limitations [40]. They lack the flexibility of a clinical 
interview, in which questions can be repeated or reformu­
lated whenever a patient does not fully understand their 
meaning. Then again the phrasing of a questionnaire is 
more standardised which we consider as preferential. Ras­
mussen et al. also m ention methodological pitfalls. They 
particularly mention the internal consistency and test- 
retest repeatability. Reliability scores of our questionnaire 
are very high (kappa: 0.982, sign.: <0.001), as well as the 
internal consistency (Cronbach alpha: 0.87) [30]. Consid­
ering these methodological aspects we believe that the use 
of this questionnaire is justified.
We preferred not to include generic questionnaires like 
the SF-36 in our outcome measures. This was mostly out 
of practical considerations: the initial set of question­
naires is quite long to complete. Adding another question­
naire can discourage patients to participate. The influence 
of migraine, tension-type headache and CEH on Quality 
O f Life (QOL) has been investigated before [41].
Quantitative Sensory Testing using thermal and pressure 
stimuli have been used to study patho-physiological 
mechanisms in headache patients [42-46]. General hyper­
sensitivity has been demonstrated to be present in Whip­
lash patients with moderate to severe symptoms and not 
in recovered patients or those with mild symptoms [47]. 
This indicates the potential value of this test in predicting 
the evolution of a disorder.
The num ber of participants is the weak point of every clin­
ical study. A pilot running from February 06 to June 06, 
with only first line recruitments resulted in 15 referred 
patients. To obtain the required number of patients the 
way of recruitment was adapted. Second line and adver­
tisement recruitments were also included. The results will 
be analysed as in any multicenter trial: intercenter differ­
ences will be analysed to verify if patients can be pooled.
No training sessions dealing with the study protocol or 
treatments were organised for the participating medical 
doctors or therapists. This is a potential weakness of the 
study protocol. It was impossible to organize these ses­
sions. The referring doctors receive no financial incentives 
or compensations whatsoever for participation in this 
study. They participate out of goodwill. Additional time 
investments would decrease this goodwill. We tried to 
have their commitment by informing them personally 
and by providing additional information on a website 
developed for that purpose [23].
The therapists could not be trained in advance either as it 
is not known in advance which therapists will participate. 
This depends on the patient's residence. Therefore the let­
ter with treatment recommendations is provided.
The treatment part of the study protocol is a potential bar­
rier for doctors to participate in the study. Clinicians have 
treatment preferences. Study protocols require a step back 
from daily routine, and maybe ask to prescribe a treat­
ment one does not fully support. This can influence the 
selection of patients: one can refer only those patients 
who do not fit in the regular schema or where the regular 
schema was not successful. To anticipate this phenom e­
non, we contacted all doctors personally, informed them 
about the study protocol and asked them to collaborate. 
We labelled one of the treatment groups as the usual care 
group to link the study protocol with every day practice 
explicitly.
Patients who are willing to participate are informed prior 
to the study (written informed consent). Patients with a 
preference for one of the treatment groups are potentially 
biased when included.
For these reasons Pfeiffer et al. decided to use a prospec­
tive cohort study rather than a randomised controlled trial 
[48]. In case a study protocol acquires a too low number 
of patients, using a non-randomised protocol can be an 
option.
With this study we hope to detect variables that can pre­
dict the outcome of the treatment of headache patients, 
and that consequently can help to improve the care for 
these patients.
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List of abbreviations
HIT-6: Headache Impact Tests, 6 items
UC: Usual Care
UCMT: Usual Care plus Musculoskeletal Physiotherapy 
Treatment
GP: General Practitioner
RCT: Randomised Clinical Trial
CEH: CErvicogenic Headache
IHS: International Headache Society
CHISG: Cervicogenic Headache International Study 
Group
VAS: Visual Analogue Scale 
QST: Quantitative Sensory Testing.
CS: Cold Sensation 
WS: Warm Sensation 
CP: Cold Pain 
HP: Heat Pain
GPE: Global Perceived Effect 
QOL: Quality Of Life
SF-8: Short form-8 quality of life questionnaire 
SF-36: Short form-36 quality of life questionnaire 
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